Thyrocare Technologies Limited — Results, 23-01-2025: Integrated Filing- Financial

Thyrocare Technologies Limited has announced a board meeting to discuss key updates, including the approval of unaudited financial results for the quarter and nine months ended December 31, 2024, reflecting a revenue of ₹152.55 Crore, up from ₹122.89 Crore a year prior. The company is also undergoing management changes with the retirement of Company Secretary Mr. Ramjee Dorai, effective January 31, 2025, and the appointment of Mr. Brijesh Kumar as his successor. Additionally, 1,651 equity shares were allotted under the Employee Stock Option Scheme, increasing the paid-up share capital. This strategic restructuring may enhance operational efficiency and potentially improve investor sentiment amidst ongoing growth initiatives.